CDSCO 2026 Sampling Guidelines: Key Compliance Updates for the Pharma Industry

CDSCO Revised Guidelines for Sampling of Drugs, Cosmetics and Medical Devices: Key Compliance Updates for 2026

The revised guidelines establish a standardized methodology for the collection, testing, monitoring, and reporting of samples by Drug Inspectors. The framework applies to drugs, cosmetics, and medical devices available in the market through manufacturers, wholesalers, retailers, hospitals, and government distribution channels.

2026-06-0176Anshika Jindal

CDSCO Revised Guidelines for Sampling of Drugs, Cosmetics and Medical Devices: Key Compliance Updates for 2026

7558640644 - Harshita

About the Author

Anshika Jindal

Content Writer

Anshika Jindal, a Legal Content Writer with strong expertise in legal research and a solid academic background in BA LLB and LLM (Criminal Law). I specialize in researching statutes, case laws, and legal developments and presenting them in clear, accurate, and engaging written content. With strong analytical skills and attention to detail, I create reliable, well-structured legal content while maintaining professional and ethical standards.

I specialize in conducting in-depth legal research using credible sources and presenting legal information in a structured, reader-friendly manner while maintaining precision and authenticity. My work focuses on simplifying legal language without compromising its meaning, making legal content accessible to a wider audience.

View profile →